We are live on
!
Find out more
UOC
UBS O'Connor Portfolio holdings
AUM
$3.76B
1-Year Est. Return
62.41%
This Fund
S&P 500
This Quarter
Est. Return
+7.76%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$4.75B
AUM Growth
+$529M
(+13%)
Cap. Flow
+$146M
Cap. Flow
% of AUM
3.08%
Top 10 Holdings %
Top 10 Hldgs %
47.97%
Holding
745
New
128
Increased
150
Reduced
259
Closed
162
Avg Time Held Equity + Options
3.8
quarters
Top 10 Avg Time Held Equity + Options
1.1
quarters
Top 20 Avg Time Held Equity + Options
1.1
quarters
Avg Time Held Equity only
3.9
quarters
Top 10 Avg Time Held Equity only
1.1
quarters
Top 20 Avg Time Held Equity only
1.1
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$253M |
| 2 |
PDCE
PDC Energy, Inc.
PDCE
|
+$210M |
| 3 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$206M |
| 4 |
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
|
+$135M |
| 5 |
LSI
Life Storage, Inc.
LSI
|
+$87.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
First Horizon
FHN
|
+$179M |
| 2 |
AQUA
Evoqua Water Technologies Corp. Common Stock
AQUA
|
+$146M |
| 3 |
PRVB
Provention Bio, Inc. Common Stock
PRVB
|
+$70.5M |
| 4 |
Tower Semiconductor
TSEM
|
+$50.8M |
| 5 |
XM
Qualtrics International Inc. Class A Common Stock
XM
|
+$45.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 32.35% |
| 2 | Technology | 15.68% |
| 3 | Financials | 11.99% |
| 4 | Miscellaneous | 10.5% |
| 5 | Real Estate | 8.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
ENER
226
DELISTED
Accretion Acquisition Corp
ENER
| $2.41M | 0.05% |
231,102
-5,209
| -2% | -$53.8K |
2021 Q4
6 quarters
|
|
227
DELISTED
Battery Future Acquisition Corp.
BFAC
| $2.4M | 0.05% |
226,579
-5,107
| -2% | -$53.8K |
2022 Q2
4 quarters
|
|
228
DELISTED
Perception Capital Corp. III Class A Ordinary Share
PFTA
| $2.4M | 0.05% |
231,102
-5,209
| -2% | -$53.7K |
2021 Q3
7 quarters
|
|
229
AstraZeneca
AZN
$247B
| $2.4M | 0.05% |
16,771
-5,829
| -26% | -$858K |
2022 Q1
5 quarters
|
|
|
KNSW
230
DELISTED
KnightSwan Acquisition Corporation
KNSW
| $2.39M | 0.05% |
226,579
-5,107
| -2% | -$53.5K |
2022 Q1
5 quarters
|
|
231
DELISTED
Project Energy Reimagined Acquisition Corp. Class A Ordinary Share
PEGR
| $2.39M | 0.05% |
231,102
-5,209
| -2% | -$53.6K |
2022 Q1
5 quarters
|
|
|
FICV
232
DELISTED
Frontier Investment Corp Class A Ordinary Shares
FICV
| $2.39M | 0.05% |
231,102
-5,209
| -2% | -$53.6K |
2021 Q3
7 quarters
|
|
233
DELISTED
Pearl Holdings Acquisition Corp Class A Ordinary Shares
PRLH
| $2.39M | 0.05% |
226,579
-5,107
| -2% | -$53.6K |
2022 Q2
4 quarters
|
|
234
Highwoods Properties
HIW
$3.2B
| $2.39M | 0.05% |
100,000
+18,048
| +22% | +$400K |
2023 Q1
1 quarter
|
|
235
DELISTED
Priveterra Acquisition Corp. II Class A Common Stock
PMGM
| $2.39M | 0.05% |
226,579
-7,374
| -3% | -$77.5K |
2021 Q3
7 quarters
|
|
236
DELISTED
Arogo Capital Acquisition Corp. Class A Common Stock
AOGO
| $2.39M | 0.05% |
226,579
-5,107
| -2% | -$53.5K |
2022 Q2
4 quarters
|
|
|
VBOC
237
DELISTED
Viscogliosi Brothers Acquisition Corp Common Stock
VBOC
| $2.39M | 0.05% |
226,579
-5,107
| -2% | -$53.2K |
2022 Q1
5 quarters
|
|
|
TGVC
238
DELISTED
TG Venture Acquisition Corp. Class A Common Stock
TGVC
| $2.38M | 0.05% |
226,579
-5,107
| -2% | -$53.2K |
2021 Q4
6 quarters
|
|
239
DELISTED
AxonPrime Infrastructure Acquisition Corporation Class A Common Stock
APMI
| $2.38M | 0.05% |
231,102
-5,209
| -2% | -$53.2K |
2021 Q4
6 quarters
|
|
240
DELISTED
CSLM Acquisition Corp. Class A Ordinary Share
CSLM
| $2.38M | 0.05% |
226,579
-5,107
| -2% | -$53.2K |
2022 Q1
5 quarters
|
|
241
Insmed
INSM
$22B
| $2.37M | 0.05% |
112,292
-99,048
| -47% | -$1.88M |
2022 Q1
5 quarters
|
|
242
EON Resources
EONR
$26.6M
| $2.36M | 0.05% |
222,542
-5,016
| -2% | -$52.9K |
2022 Q2
4 quarters
|
|
|
FGMC
243
DELISTED
FG Merger Corp. Common Stock
FGMC
| $2.35M | 0.05% |
222,542
-5,016
| -2% | -$52.6K |
2022 Q2
4 quarters
|
|
244
Fold Holdings
FLD
$32.4M
| $2.35M | 0.05% |
226,579
-5,107
| -2% | -$52.6K |
2022 Q1
5 quarters
|
|
245
DELISTED
Coliseum Acquisition Corp. Class A Ordinary Share
MITA
| $2.33M | 0.05% |
231,102
-5,209
| -2% | -$53.8K |
2021 Q3
7 quarters
|
|
|
ALCE
246
DELISTED
Alternus Clean Energy Inc
ALCE
| $2.33M | 0.05% |
8,902
-200
| -2% | -$51.8K |
2022 Q2
4 quarters
|
|
247
Riot Platforms
RIOT
$6.34B
| $2.32M | 0.05% |
196,505
+144,505
| +278% | +$1.62M |
2023 Q1
1 quarter
|
|
248
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.95B
| $2.31M | 0.05% |
56,888
+15,638
| +38% | +$638K |
2023 Q1
1 quarter
|
|
249
Arvinas
ARVN
$500M
| $2.31M | 0.05% |
93,182
+57,832
| +164% | +$1.49M |
2023 Q1
1 quarter
|
|
250
DELISTED
Informatica
INFA
| $2.31M | 0.05% |
+125,000
| New | +$2.06M |
2023 Q2
0 quarters
|
|
Similar funds
FNBT
ACI
RC
A
CGL
CB
JCM
MPM
UBS O'Connor's Q2 2023 Portfolio in Review
As of Q2 2023, UBS O'Connor held 745 positions worth $4.75B, up 13% from $4.22B the previous quarter. Its ten largest holdings account for 48% of the portfolio.
UBS O'Connor deployed $146M of net new capital in Q2 2023, opening 128 new positions and adding to 150 existing holdings. Its largest new stake was PDC Energy, Inc.: 3,101,445 shares worth $221M.
By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 21% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Tower Semiconductor, an estimated $50.8M trimmed.
- UBS O'Connor's largest Q2 2023 buy was PDC Energy, Inc.: 3,101,445 shares worth $221M.
- UBS O'Connor added most to Seagen Inc. Common Stock in Q2 2023, an estimated $253M increase.
- UBS O'Connor's biggest Q2 2023 reduction was Tower Semiconductor, cutting an estimated $50.8M.
- UBS O'Connor fully exited First Horizon in Q2 2023, selling an estimated $179M.
- UBS O'Connor's ten largest holdings make up 48% of its $4.75B portfolio in Q2 2023.
- UBS O'Connor opened 128 new positions and closed 162 in Q2 2023.
- UBS O'Connor's portfolio value rose 13% quarter-over-quarter to $4.75B.
Based on UBS O'Connor's 13F filing for Q2 2023, filed 14 Aug 2023.